Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection. - Wikidata - wikimedia - TriplyDB

Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection.

Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection.

http://www.wikidata.org/entity/Q43869901

about

Current treatment options to prevent perinatal transmission of herpes simplex virus Antiviral therapy for genital herpes for prevention of HIV transmission Effect of resiquimod 0.01% gel on lesion healing and viral shedding when applied to genital herpes lesions Effects of the immunomodulating agent R837 on acute and latent herpes simplex virus type 2 infections Episodic therapy for genital herpes in sub-saharan Africa: a pooled analysis from three randomized controlled trials.Genital herpes.Acyclovir in first attacks of genital herpes and prevention of recurrences A randomized, double-blind, comparative trial comparing high- and standard-dose oral acyclovir for first-episode genital herpes infections Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes.Labial adhesions after genital herpes infection Recent advances in management of genital herpes.Clinical Evidence: Genital herpes The role of oral acyclovir in the management of genital herpes simplex.Genital herpes: oral antiviral treatments.Estimating the costs and benefits of screening monogamous, heterosexual couples for unrecognised infection with herpes simplex virus type 2.Patient satisfaction with care for genital herpes: insights from a global survey.Acyclovir prophylaxis for herpes simplex virus infection.Pharmacokinetics of acyclovir suspension in infants and children.Use of antiviral treatment and prophylaxis is unlikely to have a major impact on the prevalence of herpes simplex virus type 2.Alteration of lymphocyte transformation response to herpes simplex virus infection by acyclovir therapy.Contemporary antiviral drug regimens for the prevention and treatment of orolabial and anogenital herpes simplex virus infection in the normal host: Four approved indications and 13 off-label uses.Primary Genital Herpes Simplex Virus Type I in Preterm Prelabour Rupture of Membranes at 30 Weeks' Gestation.Genital herpes: antiviral therapy for symptom relief and prevention of transmission.Oral acyclovir therapy of recurrent herpes simplex virus type 2 infection of the hand.Diagnosis of herpes simplex virus by direct immunofluorescence and viral isolation from samples of external genital lesions in a high-prevalence population Differentiation of primary from nonprimary genital herpesvirus infections by detection of polymeric immunoglobulin A activity.Herpes simplex virus and human papillomavirus genital infections: new and investigational therapeutic options.Development of mucoadhesive floating hollow beads of acyclovir with gastroretentive properties.Interventions for men and women with their first episode of genital herpes.Skin diseases of the vulva: Infectious diseases.Antiviral chemotherapy in genital herpes simplex virus infections.Antiviral drugs and antiviral drug resistance.Beyond efficacy: new issues for HSV antiviral therapy.Herpes Simplex Virus: Partner for Life.

P2860

Q22306018-59FFBD76-20EC-4401-AF4A-8B565915BC30 Q24234315-804B565E-F257-4F4C-B4A1-8508B5E9D81E Q24656625-0824C6FA-BB8A-4645-A65B-2EB4218F1E1B Q28340304-4EBB601B-6F12-49D2-906F-961CC41052E4 Q31028568-FAC58828-4598-4B4E-859B-19E7AE2972B3 Q33448071-32FEDA14-109F-453E-8EC7-2BFFACF104F0 Q33583052-ECECEF84-1A03-484A-BCF1-F347A3237C79 Q33748184-F5FDC34C-4F2F-4571-825F-D946A758F5E8 Q33856050-BC707276-B664-445D-8ED6-A681C3539B01 Q33932095-820046D1-CB7D-42D0-8DB8-95CA929D0FFD Q34012149-2782BF8B-C0F2-49B5-A9D6-E2EF0C3749ED Q34190888-F30DFD60-73CF-4859-B969-2AF65B04B170 Q34730907-D018E41C-8D5C-4468-9271-E9F7185EF18F Q35318973-6E712A3E-0C67-42CA-95CF-97249B19410E Q35530369-7CA59ED7-502B-4D3D-873A-1913D0C272F5 Q35531277-8FCE0ED1-89DF-4244-8410-0CCAF8D6536A Q35537506-1356EC45-5B0A-481E-9FD9-EB34B562B002 Q35543240-457A6ABA-030B-4F43-9658-C1520D256558 Q35562407-4FF2445C-4E81-444B-8254-FAD2E195905E Q35641161-67B58F80-AD2F-4186-AD02-124A0B08C136 Q36170672-2ECA6A33-2EEC-4D84-89A8-C79FA7220934 Q36327883-F54A77A5-B9DC-4311-9030-0B89FB5A5402 Q36429709-340E6356-2B84-4238-A0EE-46E5C06D28AF Q36752963-DCC8FADD-9776-463E-9033-CEE586F6FCCB Q37136139-68E46621-1142-4EA9-A263-F3F4BB0306A4 Q37163030-9F20978D-DE8E-42FE-821E-9BA5132A39D5 Q37771396-A9A375F5-7772-4B7F-A3AE-3EE9CF5F0DDE Q38425424-B408FAFF-B4C1-4F27-8C47-41A66FE445E9 Q38941189-57102052-E672-490A-844F-82F2C07743CC Q39233693-49B06248-9099-4501-8A4E-DF3853F7D7D4 Q40938400-EC1861A4-ED07-40FE-A8D0-BCEC8E6BCD39 Q42322748-5222A01D-840C-4D0D-AA94-B98EB0C3B201 Q42948638-59B3B4B5-8692-435A-A83C-611E7C7BA2A6 Q45865498-D4621B2A-2DF5-4645-AE79-823C119BF22F

P2860

Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection.

http://www.wikidata.org/entity/Q43869901

description

1984 nî lūn-bûn

@nan

1984年の論文

@ja

1984年学术文章

@wuu

1984年学术文章

@zh

1984年学术文章

@zh-cn

1984年学术文章

@zh-hans

1984年学术文章

@zh-my

1984年学术文章

@zh-sg

1984年學術文章

@yue

1984年學術文章

@zh-hant

name

Double-blind placebo-controlle ...... erpes simplex virus infection.

@en

Double-blind placebo-controlle ...... erpes simplex virus infection.

@nl

type

label

Double-blind placebo-controlle ...... erpes simplex virus infection.

@en

Double-blind placebo-controlle ...... erpes simplex virus infection.

@nl

prefLabel

Double-blind placebo-controlle ...... erpes simplex virus infection.

@en

Double-blind placebo-controlle ...... erpes simplex virus infection.

@nl

P1433

Q43869901-5484FC6A-1522-4A6C-B4EA-A2ED6A6F5CDD

P1476

Q43869901-FB7E822D-91F5-4037-93EA-E2C3C60783F8

P2093

Q43869901-31B89C3E-2E67-4A04-B461-6AF1668B3A6F

Q43869901-45CF0A35-5561-4172-9891-BD0A6C0C99A0

Q43869901-4DC1A40B-5444-4B8F-B542-4F7AF79DD847

Q43869901-5B340229-F7C8-4A93-A47E-263BB1CABAFA

Q43869901-6286CE50-2509-441B-AF67-6D1FA724C90A

Q43869901-7674C73F-96BE-4B64-8810-3A3E674ED3F5

Q43869901-96F3B925-D751-4614-B611-0997172BBAE5

Q43869901-B8021C71-4296-4CD0-90B2-A1C10164307B

Q43869901-C05DF33D-E624-4954-AF1D-B0018E59EFD9

Q43869901-FC7588C4-9D43-4258-9EA4-2B271CBFFFC9

P304

Q43869901-F08F29A4-A9D0-4978-9605-7FC2292DC674

P31

Q43869901-83AAC5C7-AA3C-41CC-8156-9E492333F380

P356

Q43869901-63556CF2-3FCF-4F90-8CC9-3FFC4181C3E4

P407

Q43869901-81FCEEE7-66D4-44E2-956E-0D38F71DB122

P433

Q43869901-96B4D4D2-5C13-45B7-812F-378222D18635

P478

Q43869901-895D8D0A-8B21-430A-BDAB-98BE16394264

P577

Q43869901-004969F2-61F0-4646-B0C7-CE50CD003C71

P698

Q43869901-5FF896BD-2BC9-46ED-A5B2-D0326E917CAE

P921

Q43869901-FE406B04-4246-43C5-8A67-24C2B1EC216D

P356

JAMA.1984.03350090023017

P1433

Journal of the American Medical Association

P1476

Double-blind placebo-controlle ...... erpes simplex virus infection.

@en

P2093

C W Critchlow

http://www.w3.org/2001/XMLSchema#string

D C Redfield

http://www.w3.org/2001/XMLSchema#string

D D Richman

http://www.w3.org/2001/XMLSchema#string

D L Tyrrell

http://www.w3.org/2001/XMLSchema#string

G J Mertz

http://www.w3.org/2001/XMLSchema#string

J Benedetti

http://www.w3.org/2001/XMLSchema#string

J Connor

http://www.w3.org/2001/XMLSchema#string

M C Savoia

http://www.w3.org/2001/XMLSchema#string

R C Reichman

http://www.w3.org/2001/XMLSchema#string

R Dolin

http://www.w3.org/2001/XMLSchema#string

P304

1147-1151

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.1984.03350090023017

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

252

http://www.w3.org/2001/XMLSchema#string

P577

1984-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

6088819

http://www.w3.org/2001/XMLSchema#string

P921